UBS Group’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
Other funds holding CAH
UBS Group's CAH Position: Q3 2026 in Review
UBS Group increased its Cardinal Health (CAH) stake by 30% in Q3 2026, buying an estimated $65.2M and bringing the position to 1,201,244 shares worth $267M. The position accounts for 0.03% of the portfolio, ranked #509.
UBS Group first reported a position in CAH in Q4 2014 and has held it in 48 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q3 2026.
- UBS Group held 1,201,244 shares of Cardinal Health worth $267M as of Q3 2026.
- UBS Group bought 280,294 Cardinal Health shares in Q3 2026, an estimated $65.2M.
- Cardinal Health made up 0.03% of UBS Group's portfolio in Q3 2026, its #509 holding.
- UBS Group first reported a position in Cardinal Health in Q4 2014 and has held it in 48 quarters since.
- 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.